JCHO Sendai Hospital

Sendai, Miyagi 981-3281

0 studies enrolling now · 2 studies all time

What they study most

Alport Syndrome, Autosomal Dominant Polycystic Kidney, Chronic Kidney Diseases, Immunoglobulin A (IgA) Nephropathy

Studies at this site

• Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy — Completed
• An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE) — Stopped early